Alamar Biosciences Raises $128M in Oversubscribed Series C
- Feb 28, 2024
- 1 min read
Fremont, CA, February 26, 2024 (PRNewswire) -- Alamar Biosciences, a company specializing in precision proteomics for early disease detection, announced the close of $100 million in Series C financing today, with an additional $28 million expected to be closed within the next 30 days. This additional capital increases Alamar's total funding to nearly $250 million.
Read full article here.
Comments